Sarissa Capital Acquisition Corp.

Sarissa Capital Acquisition Corp. (Nasdaq: SRSA) is a blank-check company sponsored by Sarissa Capital Management, the healthcare-focused activist investment firm led by Alex Denner. The SPAC completed its initial public offering in 2021 and filed its quarterly report on Form 10-Q with the SEC on August 23, 2021, under accession number 0001193125-21-254052. SRSA was formed with a stated focus on identifying and completing a business combination in the biopharmaceutical and life sciences sector, consistent with Sarissa Capital's established expertise in healthcare investing. At the time of filing, the company remained in its search phase, having not yet announced a definitive merger target. Visit SpacDesk and sign up for full data, filings, and deal-tracking on SRSA and hundreds of other active SPACs.